Trials / Terminated
TerminatedNCT03500562
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
Daclatasvir-Based Therapy Safety Surveillance in Chinese Patients With Chronic Hepatitis C
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study is a non-interventional, prospective, multicenter post marketing surveillance study to determine the safety of daclatasvir based therapy
Conditions
Timeline
- Start date
- 2018-05-08
- Primary completion
- 2019-03-29
- Completion
- 2019-03-29
- First posted
- 2018-04-18
- Last updated
- 2021-09-01
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03500562. Inclusion in this directory is not an endorsement.